Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-24-000523
Filing Date
2024-12-17
Accepted
2024-12-17 17:24:40
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 12-13-2024 form4.html 4  
1 FORM 4 FOR 12-13-2024 form4.xml 4 5459
  Complete submission text file 0001161697-24-000523.txt   7161
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address
Miller Steve (Reporting) CIK: 0001402535 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 241556803